3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
23
Recurrence
3
Neoplasms, Plasma Cell
2
Lymphoma
2
beta-Thalassemia
1
Thalassemia
1
Sarcoma, Myeloid
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Neoplasms
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphadenopathy
1
Leukemia, Myeloid, Acute
1
HIV Infections
1
Anemia, Sickle Cell
1
Interventions
Waiting Lists
1
High-Intensity Interval Training
1
Hematologic Tests
1
Fluorodeoxyglucose F18
1
Exercise
1
Educational Status
1
Bupivacaine
1
Acupressure
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease
×
Bortezomib
×
30 days
×
Clear all
No trials found.